Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 311

1.

Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.

Tripodi A, Ammollo CT, Semeraro F, Colucci M, Malchiodi E, Verrua E, Ferrante E, Arnaldi G, Trementino L, Padovan L, Chantarangkul V, Peyvandi F, Mantovani G.

Endocrine. 2016 Jul 22. [Epub ahead of print]

PMID:
27448294
2.

Genomic approaches to bleeding disorders.

Peyvandi F, Hayward CP.

Haemophilia. 2016 Jul;22 Suppl 5:42-5. doi: 10.1111/hae.12998.

PMID:
27405675
3.

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

Peyvandi F, Callewaert F.

N Engl J Med. 2016 Jun 23;374(25):2497-8. doi: 10.1056/NEJMc1603180. No abstract available.

PMID:
27332911
4.

Factors Associated with Anxiety in Premature Coronary Artery Disease Patients: THC-PAC Study.

Abbasi SH, Kassaian SE, Sadeghian S, Karimi A, Saadat S, Peyvandi F, Jalali A, Davarpasand T, Akhondzadeh S, Shahmansouri N, Boroumand MA, Lotfi-Tokaldany M, Amiri Abchouyeh M, Ayatollahzade Isfahani F, Rosendaal F.

Acta Med Iran. 2016 Apr;54(4):261-9.

5.

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.

Peyvandi F, Mannucci PM, Garagiola I, El-Beshlawy A, Elalfy M, Ramanan V, Eshghi P, Hanagavadi S, Varadarajan R, Karimi M, Manglani MV, Ross C, Young G, Seth T, Apte S, Nayak DM, Santagostino E, Mancuso ME, Sandoval Gonzalez AC, Mahlangu JN, Bonanad Boix S, Cerqueira M, Ewing NP, Male C, Owaidah T, Soto Arellano V, Kobrinsky NL, Majumdar S, Perez Garrido R, Sachdeva A, Simpson M, Thomas M, Zanon E, Antmen B, Kavakli K, Manco-Johnson MJ, Martinez M, Marzouka E, Mazzucconi MG, Neme D, Palomo Bravo A, Paredes Aguilera R, Prezotti A, Schmitt K, Wicklund BM, Zulfikar B, Rosendaal FR.

N Engl J Med. 2016 May 26;374(21):2054-64. doi: 10.1056/NEJMoa1516437.

PMID:
27223147
6.

Plasma factor XIII level variations during menstrual cycle.

Sharief LA, Lawrie AS, Mackie IJ, Halimeh S, Kappert G, Smith C, Peyvandi F, Kadir RA.

Blood Coagul Fibrinolysis. 2016 May 20. [Epub ahead of print]

PMID:
27214035
7.

Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents.

Mancuso ME, Chantarangkul V, Clerici M, Fasulo MR, Padovan L, Scalambrino E, Peyvandi F, Tripodi A, Santagostino E.

Haemophilia. 2016 Jul;22(4):e292-300. doi: 10.1111/hae.12939. Epub 2016 May 16.

PMID:
27197961
8.

Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency.

Austin SK, Kavakli K, Norton M, Peyvandi F, Shapiro A; FX Investigators Group.

Haemophilia. 2016 May;22(3):419-25. doi: 10.1111/hae.12893. Epub 2016 Mar 8.

PMID:
27197801
9.

The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A.

Mancuso ME, Chantarangkul V, Clerici M, Fasulo MR, Padovan L, Scalambrino E, Peyvandi F, Tripodi A, Santagostino E.

Haemophilia. 2016 Jul;22(4):e286-91. doi: 10.1111/hae.12927. Epub 2016 May 11.

PMID:
27166132
10.

Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.

Colucci M, Incampo F, Cannavò A, Menegatti M, Siboni SM, Zaccaria F, Semeraro N, Peyvandi F.

J Thromb Haemost. 2016 Apr 20. doi: 10.1111/jth.13342. [Epub ahead of print]

PMID:
27094709
11.

A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients: evidence for a founder effect.

Garagiola I, Seregni S, Mortarino M, Mancuso ME, Fasulo MR, Notarangelo LD, Peyvandi F.

Mol Genet Genomic Med. 2015 Dec 14;4(2):152-9. doi: 10.1002/mgg3.189. eCollection 2016 Mar.

12.

Pregnancy loss and risk of ischaemic stroke and myocardial infarction.

Maino A, Siegerink B, Algra A, Martinelli I, Peyvandi F, Rosendaal FR.

Br J Haematol. 2016 Jul;174(2):302-9. doi: 10.1111/bjh.14043. Epub 2016 Apr 7.

PMID:
27061416
13.

Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients.

Gorski MM, Blighe K, Lotta LA, Pappalardo E, Garagiola I, Mancini I, Mancuso ME, Fasulo MR, Santagostino E, Peyvandi F.

Blood. 2016 Jun 9;127(23):2924-33. doi: 10.1182/blood-2015-12-685735. Epub 2016 Apr 8.

PMID:
27060170
14.

Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.

Martinelli I, Maino A, Abbattista M, Bucciarelli P, Passamonti SM, Artoni A, Gianniello F, Peyvandi F.

Thromb Res. 2016 May;141:153-7. doi: 10.1016/j.thromres.2016.03.025. Epub 2016 Mar 23.

PMID:
27043069
15.

Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis.

Gorski MM, Lotta LA, Pappalardo E, de Haan HG, Passamonti SM, van Hylckama Vlieg A, Martinelli I, Peyvandi F.

PLoS One. 2016 Mar 16;11(3):e0151347. doi: 10.1371/journal.pone.0151347. eCollection 2016.

16.

The past and future of haemophilia: diagnosis, treatments, and its complications.

Peyvandi F, Garagiola I, Young G.

Lancet. 2016 Jul 9;388(10040):187-97. doi: 10.1016/S0140-6736(15)01123-X. Epub 2016 Feb 18. Review.

PMID:
26897598
17.

Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human Disease.

Rubattu S, Di Castro S, Schulz H, Geurts AM, Cotugno M, Bianchi F, Maatz H, Hummel O, Falak S, Stanzione R, Marchitti S, Scarpino S, Giusti B, Kura A, Gensini GF, Peyvandi F, Mannucci PM, Rasura M, Sciarretta S, Dwinell MR, Hubner N, Volpe M.

J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.

18.

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators.

N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533.

19.

Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.

Siboni SM, Biguzzi E, Caiani V, Mistretta C, Bucciarelli P, Peyvandi F.

Haemophilia. 2016 Jul;22(4):564-9. doi: 10.1111/hae.12900. Epub 2016 Feb 4.

PMID:
26843468
20.

A critical appraisal of one-stage and chromogenic assays of factor VIII activity.

Peyvandi F, Oldenburg J, Friedman KD.

J Thromb Haemost. 2016 Feb;14(2):248-61. doi: 10.1111/jth.13215. Epub 2016 Feb 1. Review.

PMID:
26663865
Items per page

Supplemental Content

Loading ...
Write to the Help Desk